Directorio

In the TRANSFORM study, the team will check your medical history and medicines. They will measure your height, weight, blood pressure, and waist size. If your recent lab results are not in your records, they will take a blood sample to check things like cholesterol, blood sugar, liver and kidney health, and inflammation. You will get these results. Another blood sample will be saved for future research to learn more about heart disease and your DNA, but you will not get those results. If your numbers are in the right range, you will have a special heart scan called a coronary CT.

We are doing this study to help women regain bladder strength and function after having their first baby. We want to find out which treatment options work best to stop bladder leakage.

We are doing this study to get a better understanding of why people are at higher risk of developing arthritis after ACL reconstruction surgery. We hope the information from this study can help improve recovery techniques and lower the risk of developing knee arthritis for people who have ACL surgery. We are partnering with UNC-Chapel Hill to do this study.

We are doing this study to evaluate the safety and effectiveness of a drug called isatuximab when it is used in combination with lenalidomide and dexamethasone at lower doses. We want to know if this low dose combination can help patients with multiple myeloma achieve a better response while causing fewer or less severe side effects.

We are doing this study to learn more about variants in people's genes that cause cells in the back of the eye to function incorrectly and lead to a process called "retinal degeneration."

The goal of this study is to learn more about how certain hormones and cells in the pancreas help keep blood sugar at a healthy level. This is very important when the body does not respond well to insulin, which can happen with obesity and diabetes. By doing this study, researchers hope to find better ways to care for and treat diabetes.

We are doing this study is to compare the effects of Urolithin A and placebo (an inactive substance with no medicinal properties) on the biological composition of the prostate in men with prostate cancer. In this study, you will have an equal chance of either taking Urolithin A or placebo.

We are doing this study to collect information about our state-of-the-art methods to care for the bladder and kidneys of babies born with spina bifida. We want to compare the results of these methods with other hospitals around the country that are following the same guidelines to protect the bladder and kidney health of infants with spina bifida. We and the other centers following these guidelines will regularly evaluate the outcomes of this care and modify the methods accordingly.